Special Offer Tirzepatide
US$ 28.34
glp-1 agonist alzheimer's Microdosing, Brain Health & Prevention He's Betting on a GLP-1
Description
C.AtkinS
:max_bytes(150000):strip_icc()/DiabetesMentalHealth2-73d13703a7c3442ca4fce0a2e71f15b0.jpg)
Users can track their points throughout the day using the WW app
27 Investigators evaluated the safety, efficacy, and tolerability of three therapies when added to metformin: exenatide (Byetta, Amylin), sitagliptin, and pioglitazone
The drug was first approved in 2010, but the problem was that a patient had to inject it daily
The rationale for a GLP-1 drug is its powerful body-wide and brain anti-inflammatory properties, says Eric Topol, a cardiologist and the director of the La Jolla, California-based Scripps Research Translational Institute, which is sponsoring the trial
